1. Home
  2. RVMD vs ATR Comparison

RVMD vs ATR Comparison

Compare RVMD & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • ATR
  • Stock Information
  • Founded
  • RVMD 2014
  • ATR 1992
  • Country
  • RVMD United States
  • ATR United States
  • Employees
  • RVMD N/A
  • ATR N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • ATR Plastic Products
  • Sector
  • RVMD Health Care
  • ATR Industrials
  • Exchange
  • RVMD Nasdaq
  • ATR Nasdaq
  • Market Cap
  • RVMD 10.2B
  • ATR 11.7B
  • IPO Year
  • RVMD 2020
  • ATR 1993
  • Fundamental
  • Price
  • RVMD $56.75
  • ATR $171.52
  • Analyst Decision
  • RVMD Strong Buy
  • ATR Strong Buy
  • Analyst Count
  • RVMD 12
  • ATR 4
  • Target Price
  • RVMD $59.25
  • ATR $195.00
  • AVG Volume (30 Days)
  • RVMD 1.5M
  • ATR 285.2K
  • Earning Date
  • RVMD 11-06-2024
  • ATR 10-24-2024
  • Dividend Yield
  • RVMD N/A
  • ATR 1.05%
  • EPS Growth
  • RVMD N/A
  • ATR 18.33
  • EPS
  • RVMD N/A
  • ATR 4.98
  • Revenue
  • RVMD $742,000.00
  • ATR $3,573,282,000.00
  • Revenue This Year
  • RVMD N/A
  • ATR $4.12
  • Revenue Next Year
  • RVMD $300.00
  • ATR $5.48
  • P/E Ratio
  • RVMD N/A
  • ATR $34.42
  • Revenue Growth
  • RVMD N/A
  • ATR 3.73
  • 52 Week Low
  • RVMD $20.98
  • ATR $122.29
  • 52 Week High
  • RVMD $62.40
  • ATR $178.03
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 58.35
  • ATR 56.86
  • Support Level
  • RVMD $53.69
  • ATR $165.65
  • Resistance Level
  • RVMD $58.83
  • ATR $178.03
  • Average True Range (ATR)
  • RVMD 2.11
  • ATR 2.72
  • MACD
  • RVMD -0.44
  • ATR -0.80
  • Stochastic Oscillator
  • RVMD 35.13
  • ATR 52.48

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Share on Social Networks: